Kingella kingaeSurface Polysaccharides Promote Resistance to Neutrophil Phagocytosis and Killing
ABSTRACTBacterial pathogens have evolved strategies that enable them to evade neutrophil-mediated killing. The Gram-negative coccobacillusKingella kingaeis an emerging pediatric pathogen and is increasingly recognized as a common etiological agent of osteoarticular infections and bacteremia in young children.K. kingaeproduces a polysaccharide capsule and an exopolysaccharide, both of which are important for protection against complement-mediated lysis and are required for full virulence in an infant rat model of infection. In this study, we examined the role of theK. kingaepolysaccharide capsule and exopolysaccharide in protection against neutrophil killing. In experiments with primary human neutrophils, we found that the capsule interfered with the neutrophil oxidative burst response and prevented neutrophil binding ofK. kingaebut had no effect on neutrophil internalization ofK. kingae. In contrast, the exopolysaccharide resisted the bactericidal effects of antimicrobial peptides and efficiently blocked neutrophil phagocytosis ofK. kingae. This work demonstrates that theK. kingaepolysaccharide capsule and exopolysaccharide promote evasion of neutrophil-mediated killing through distinct yet complementary mechanisms, providing additional support for theK. kingaesurface polysaccharides as potential vaccine antigens. In addition, these studies highlight a novel interplay between a bacterial capsule and a bacterial exopolysaccharide and reveal new properties for a bacterial exopolysaccharide, with potential applicability to other bacterial pathogens.IMPORTANCEKingella kingaeis a Gram-negative commensal in the oropharynx and represents a leading cause of joint and bone infections in young children. The mechanisms by whichK. kingaeevades host innate immunity during pathogenesis of disease remain poorly understood. In this study, we established that theK. kingaepolysaccharide capsule and exopolysaccharide function independently to protectK. kingaeagainst reactive oxygen species (ROS) production, neutrophil phagocytosis, and antimicrobial peptides. These results demonstrate the intricacies ofK. kingaeinnate immune evasion and provide valuable information that may facilitate development of a polysaccharide-based vaccine againstK. kingae.